Detalhe da pesquisa
1.
Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy.
J Am Acad Dermatol
; 79(6): 1081-1088, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30025829
2.
Implications of the EMPA-REG Trial for Clinical Care and Research.
Curr Diab Rep
; 16(12): 131, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27812962
3.
Targeting of SUMOylation leads to cBAF complex stabilization and disruption of the SS18::SSX transcriptome in Synovial Sarcoma.
bioRxiv
; 2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38712286
4.
MYCN upregulates the transsulfuration pathway to suppress the ferroptotic vulnerability in MYCN-amplified neuroblastoma.
Cell Stress
; 6(2): 21-29, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35174317
5.
Immune cells and their inflammatory mediators modify ß cells and cause checkpoint inhibitor-induced diabetes.
JCI Insight
; 7(17)2022 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35925682
6.
Elective Colectomy in a Patient with Active Ulcerative Colitis and Metastatic Melanoma Enabling Successful Treatment with Immune Checkpoint Inhibitors.
Clin Oncol Case Rep
; 3(5)2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33778814
7.
Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors.
Diabetes
; 67(8): 1471-1480, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29937434